FOBAX
Price
$20.91
Change
+$0.20 (+0.97%)
Updated
Aug 4 closing price
Net Assets
82.56M
RLBBX
Price
$36.63
Change
-$0.20 (-0.54%)
Updated
Aug 5 closing price
Net Assets
253.92B
Interact to see
Advertisement

FOBAX vs RLBBX

Header iconFOBAX vs RLBBX Comparison
Open Charts FOBAX vs RLBBXBanner chart's image
Tributary Balanced Instl
Price$20.91
Change+$0.20 (+0.97%)
VolumeN/A
Net Assets82.56M
American Funds American Balanced R2
Price$36.63
Change-$0.20 (-0.54%)
VolumeN/A
Net Assets253.92B
FOBAX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FOBAX vs. RLBBX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOBAX is a StrongBuy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 254B vs. FOBAX (82.6M). FOBAX (1.22) and RLBBX (1.16) have matching dividends . FOBAX was incepted earlier than RLBBX: FOBAX (29 years) vs RLBBX (23 years). RLBBX (1.32) and FOBAX (1.31) have similar cost to investors . RLBBX is a more actively managed with annual turnover of: 44.00 vs. FOBAX (22.00). RLBBX has a lower initial minimum investment than FOBAX: RLBBX (250) vs FOBAX (1000). RLBBX annual gain was more profitable for investors over the last year : 8.94 vs. FOBAX (6.01). RLBBX return over 5 years is better than : 33.26 vs. FOBAX (17.04).
FOBAXRLBBXFOBAX / RLBBX
Total Expense Ratio0.951.3272%
Annual Report Gross Expense Ratio1.311.3299%
Fund Existence29 years23 years-
Gain YTD5.4188.44064%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets82.6M254B0%
Annual Yield % from dividends1.221.16105%
Returns for 1 year6.018.9467%
Returns for 3 years18.4029.0463%
Returns for 5 years17.0433.2651%
Returns for 10 years30.6058.2553%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYCN2.790.19
+7.43%
Cyclerion Therapeutics
HAFN5.640.17
+3.11%
Hafnia Limited
LXU7.770.22
+2.91%
LSB Industries
IMRX3.430.06
+1.78%
Immuneering Corp
LII600.48-5.39
-0.89%
Lennox International